{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:54:54Z","timestamp":1790754894290,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Hereditary spherocytosis (HS) is one of the most common hereditary haemolytic disorders. Here, two unrelated families with the probands displaying typical manifestations of HS were enrolled. Our study aimed to characterize the effect of two novel variants in HS patients on gene splicing to help minimize the rate of misdiagnosis of HS and enhance clinicians\u2019 understanding of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Participants and methods<\/jats:title>\n                <jats:p>A retrospective review was conducted. Peripheral blood samples were collected from all the family members, and genomic DNA was extracted for genetic diagnostics. First, high-throughput sequencing technology was used for the preliminary screening of candidate causative variants. Thereafter, the variants were verified via Sanger sequencing. Furthermore, a pathogenicity analysis of the detected variants was performed including in silico prediction and in vitro experiments. We constructed matched wild-type and mutant-type minigene plasmid of <jats:italic>ANK1<\/jats:italic> based on HEK293T cells to address the effects of variants on mRNA splicing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The c.1305\u2009+\u20092\u2009T\u2009&gt;\u2009A (family1) and c.1305\u2009+\u20092del (family2) variants were detected in the <jats:italic>ANK1<\/jats:italic> gene. These two de novo mutations described by us which have not been reported prior to this study. Moreover, the validation results of splicing reporter systems revealed that the intronic mutations resulted in abnormal pre-mRNA splicing. Specifically, the minigene plasmid expressing the c.1305\u2009+\u20092\u2009T\u2009&gt;\u2009A variant transcribed the two aberrant transcripts: r.1305_1306ins1305\u2009+\u20091_1305\u2009+\u2009229 and r.1305_1306ins1305\u2009+\u20091_1305\u2009+\u2009552. The minigene plasmid expressing c.1305\u2009+\u20092del transcribed the two aberrant transcripts: r.1305_1306ins1305\u2009+\u20091_1305\u2009+\u2009228 and r.1305_1306ins1305\u2009+\u20091_1305\u2009+\u2009551.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The two de novo variants identified in the <jats:italic>ANK1<\/jats:italic> gene were the genetic etiology of the probands with HS in our study. Our findings further enrich the HS genotype database and provide a basis for genetic counselling and molecular diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03795-0","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:02:54Z","timestamp":1673848974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["De novo variations of ANK1 gene caused hereditary spherocytosis in two Chinese children by affecting pre-mRNA splicing"],"prefix":"10.1186","volume":"23","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhou","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwei","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"3795_CR1","doi-asserted-by":"crossref","unstructured":"Matossian M, Warrier R, Kattar N. Concurrent presentations of hereditary spherocytosis and Craniosynostosis syndromes in siblings: a case series. Clin Pediatr. 2021:151\u20133.","DOI":"10.1177\/0009922820987110"},{"key":"3795_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/bjh.16750","volume":"191","author":"S Tole","year":"2020","unstructured":"Tole S, Dhir P, Pugi J, Drury LJ, Butchart S, Fantauzzi M, et al. Genotype-phenotype correlation in children with hereditary spherocytosis. Br J Haematol. 2020;191:486\u201396.","journal-title":"Br J Haematol"},{"key":"3795_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3324\/haematol.2018.188151","volume":"105","author":"R Huisjes","year":"2020","unstructured":"Huisjes R, Makhro A, Llaudet PE, Hertz L, Petkova KP, Verhagen Liesbeth P, et al. Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis. Haematologica. 2020;105:338\u201347.","journal-title":"Haematologica"},{"key":"3795_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000495339","volume":"141","author":"AM Agarwal","year":"2019","unstructured":"Agarwal AM. Ankyrin mutations in hereditary spherocytosis. Acta Haematol. 2019;141:63\u20134.","journal-title":"Acta Haematol"},{"key":"3795_CR5","doi-asserted-by":"publisher","first-page":"e38999","DOI":"10.1371\/journal.pone.0038999","volume":"7","author":"A Greth","year":"2012","unstructured":"Greth A, Lampkin S, Mayura GP, Rodda F, Drysdale K, Roberts TM, et al. A novel ENU-mutation in ankyrin-1 disrupts malaria parasite maturation in red blood cells of mice. PLoS One. 2012;7:e38999.","journal-title":"PLoS One"},{"key":"3795_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11427-017-9232-6","volume":"61","author":"R Wang","year":"2018","unstructured":"Wang R, Yang S, Xu M, Huang J, Liu H, Gu W, et al. Exome sequencing confirms molecular diagnoses in 38 Chinese families with hereditary spherocytosis. Sci China Life Sci. 2018;61:947\u201353.","journal-title":"Sci China Life Sci"},{"key":"3795_CR7","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1097\/RLU.0000000000002489","volume":"44","author":"E Gomez","year":"2019","unstructured":"Gomez E, Tran PT, Pienta Kenneth J, Pomper Martin G, Gorin Michael A, Rowe SP. Hereditary spherocytosis presenting as diffuse bone marrow activation and splenomegaly on PSMA-targeted 18F-DCFPyL PET\/CT. Clin Nucl Med. 2019;44:e313\u20134.","journal-title":"Clin Nucl Med"},{"key":"3795_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","volume":"686","author":"B Gulbis","year":"2010","unstructured":"Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surrall\u00e9s J, Castella M, et al. Epidemiology of rare anaemias in Europe. Adv Exp Med Biol. 2010;686:375\u201396.","journal-title":"Adv Exp Med Biol"},{"key":"3795_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5582\/irdr.2015.01002","volume":"4","author":"C Wang","year":"2015","unstructured":"Wang C, Cui Y, Li Y, Liu X, Han J. A systematic review of hereditary spherocytosis reported in Chinese biomedical journals from 1978 to 2013 and estimation of the prevalence of the disease using a disease model. Intractable Rare Dis Res. 2015;4:76\u201381.","journal-title":"Intractable Rare Dis Res"},{"key":"3795_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/ijlh.12335","volume":"37","author":"MJ King","year":"2015","unstructured":"King MJ, Gar\u00e7on L, Hoyer JD, Iolascon A, Picard V, Stewart G, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;37:304\u201325.","journal-title":"Int J Lab Hematol"},{"key":"3795_CR11","doi-asserted-by":"publisher","first-page":"827560","DOI":"10.3389\/fgene.2022.827560","volume":"13","author":"L Fan","year":"2022","unstructured":"Fan L, Ji L, Xu Y, Shen G, Tang K, Li Z, et al. A novel mutation c.3392G>T of COL2A1 causes Spondyloepiphyseal dysplasia congenital by affecting pre-mRNA splicing. Front Genet. 2022;13:827560. https:\/\/doi.org\/10.3389\/fgene.2022.827560 PMID: 35692839; PMCID: PMC9174977.","journal-title":"Front Genet"},{"key":"3795_CR12","doi-asserted-by":"publisher","unstructured":"Xiong HY, Shi YQ, Zhong C, Yang Q, Zhang G, Yang H, et al. Detection of De novo PAX2 variants and phenotypes in Chinese population: a single-center study. Front Genet. 2022;(13):799562. https:\/\/doi.org\/10.3389\/fgene.2022.799562 PMID: 35444690; PMCID: PMC9014304.","DOI":"10.3389\/fgene.2022.799562"},{"issue":"3","key":"3795_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535\u2013548.e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015. Epub 2019 Jan 17. PMID: 30661751.","journal-title":"Cell"},{"issue":"12","key":"3795_CR14","doi-asserted-by":"publisher","first-page":"e24034","DOI":"10.1002\/jcla.24034","volume":"35","author":"Y Wu","year":"2021","unstructured":"Wu Y, Liao L, Lin F. The diagnostic protocol for hereditary spherocytosis-2021 update. J Clin Lab Anal. 2021;35(12):e24034. https:\/\/doi.org\/10.1002\/jcla.24034 Epub 2021 Oct 24. PMID: 34689357; PMCID: PMC8649336.","journal-title":"J Clin Lab Anal"},{"key":"3795_CR15","first-page":"311","volume":"487","author":"PC Lin","year":"2018","unstructured":"Lin PC, Chiou SS, Lin CY, Wang SC, Huang HY, Chang YS, et al. Whole-exome sequencing for the genetic diagnosis of congenital red blood cell membrane disorders in Taiwan. Int J Clin Chey. 2018;487:311\u20137.","journal-title":"Int J Clin Chey"},{"key":"3795_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12887-019-1436-4","volume":"19","author":"TL Huang","year":"2019","unstructured":"Huang TL, Sang BH, Lei QL, Song CY, Lin YB, Lv Y, et al. A de novo ANK1 mutation associated to hereditary spherocytosis: a case report. BMC Pediatr. 2019;19:62.","journal-title":"BMC Pediatr"},{"issue":"1","key":"3795_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41439-021-00179-1","volume":"9","author":"KS Yamamoto","year":"2022","unstructured":"Yamamoto KS, Utshigisawa T, Ogura H, Aoki T, Kawakami T, Ohga S, et al. Clinical and genetic diagnosis of thirteen Japanese patients with hereditary spherocytosis. Hum Genome Var. 2022;9(1):1. https:\/\/doi.org\/10.1038\/s41439-021-00179-1 PMID: 35022413; PMCID: PMC8755803.","journal-title":"Hum Genome Var"},{"key":"3795_CR18","doi-asserted-by":"publisher","first-page":"644352","DOI":"10.3389\/fphar.2021.644352","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang D, Song L, Shen L, Zhang K, Lv Y, Gao M, et al. Mutational characteristics of causative genes in Chinese hereditary spherocytosis patients: a report on fourteen cases and a review of the literature. Front Pharmacol. 2021;12:644352. https:\/\/doi.org\/10.3389\/fphar.2021.644352 PMID: 34335240; PMCID: PMC8322660.","journal-title":"Front Pharmacol"},{"issue":"7","key":"3795_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","volume":"20","author":"T Kurosaki","year":"2019","unstructured":"Kurosaki T, Popp MW, Maquat LE. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol. 2019;20(7):406\u201320. https:\/\/doi.org\/10.1038\/s41580-019-0126-2 Erratum in: Nat Rev Mol Cell Biol. 2019 Apr 26; PMID: 30992545; PMCID: PMC6855384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3795_CR20","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jmoldx.2021.07.024","volume":"23","author":"P Rofes","year":"2021","unstructured":"Rofes P, Gonz\u00e1lez S, Navarro M, Moreno-Cabrera JM, Solanes A, Darder E, et al. Paired somatic-germline testing of 15 polyposis and colorectal Cancer-predisposing genes highlights the role of APC mosaicism in de novo familial adenomatous polyposis. J Mol Diagn. 2021;23:1452\u20139.","journal-title":"J Mol Diagn"},{"key":"3795_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1182\/hematology.2021000265","volume":"2021","author":"TA Kalfa","year":"2021","unstructured":"Kalfa TA. Diagnosis and clinical management of red cell membrane disorders. Hematol Am Soc Hematol Educ Program. 2021;2021:331\u201340.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3795_CR22","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1097\/MPH.0000000000002211","volume":"44","author":"MA Kili\u00e7","year":"2022","unstructured":"Kili\u00e7 MA, \u00d6zdemir GN, Tahtakesen TN, G\u00f6k\u00e7e M, Uysalol EP, Bayram C, et al. Clinical features and outcome of children with hereditary spherocytosis. J Pediatr Hematol Oncol. 2022;44:e306\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3795_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/asheducation-2018.1.377","volume":"2018","author":"N Mohandas","year":"2018","unstructured":"Mohandas N. Inherited hemolytic anemia: a possessive beginner's guide. Hematol Am Soc Hematol Educ Program. 2018;2018:377\u201381.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3795_CR24","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1182\/blood-2015-11-679357","volume":"127","author":"T Pincez","year":"2016","unstructured":"Pincez T, Guitton C, Gauthier F, de Lambert G, Picard V, F\u00e9n\u00e9ant-Thibault M, et al. Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study. Blood. 2016;127:1616\u20138.","journal-title":"Blood."},{"key":"3795_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ajh.23888","volume":"90","author":"HE Rice","year":"2015","unstructured":"Rice HE, Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, et al. Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry. Am J Hematol. 2015;90:187\u201392.","journal-title":"Am J Hematol"},{"key":"3795_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1182\/blood-2011-09-377630","volume":"119","author":"C Binny","year":"2012","unstructured":"Binny C, McIntosh J, Della Peruta M, Kymalainen H, Tuddenham EG, Buckley SM, et al. AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage. Blood. 2012;119:957\u201366.","journal-title":"Blood."},{"key":"3795_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtn.2016.11.010","volume":"6","author":"Y Liu","year":"2017","unstructured":"Liu Y, Yang Y, Kang X, Lin B, Yu Q, Song B, et al. One-step Biallelic and Scarless correction of a \u03b2-thalassemia mutation in patient-specific iPSCs without drug selection. Mol Ther Nucleic Acids. 2017;6:57\u201367.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3795_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/sctm.17-0066","volume":"7","author":"L Cai","year":"2018","unstructured":"Cai L, Bai H, Mahairaki V, Gao Y, He C, Wen Y, et al. A universal approach to correct various HBB gene mutations in human stem cells for gene therapy of Beta-thalassemia and sickle cell disease. Stem Cells Transl Med. 2018;7:87\u201397.","journal-title":"Stem Cells Transl Med"},{"key":"3795_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.omtm.2021.05.001","volume":"22","author":"S Fa\u00f1anas-Baquero","year":"2021","unstructured":"Fa\u00f1anas-Baquero S, Quintana-Bustamante O, Dever DP, Alberquilla O, Sanchez-Dominguez R, Camarena J, et al. Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency. Mol Ther Methods Clin Dev. 2021;22:237\u201348.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3795_CR30","doi-asserted-by":"publisher","first-page":"14848","DOI":"10.1038\/ncomms14848","volume":"8","author":"A Malerba","year":"2017","unstructured":"Malerba A, Klein P, Bachtarzi H, Jarmin SA, Cordova G, Ferry A, et al. PABPN1 gene therapy for oculopharyngeal muscular dystrophy. Nat Commun. 2017;8:14848.","journal-title":"Nat Commun"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03795-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:05:14Z","timestamp":1673849114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03795-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3795"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03795-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of the Children\u2019s Hospital of Chongqing Medical University with the approval file number 2021.456. Written informed consents were obtained from all patients or legal guardians before the investigation. All methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}